Evidence map›Paper›PMID 40903878›Full record

ArticleGut microbes2025

Gut microbiota dysbiosis affects intestinal sensitivity through epithelium-to-neuron signaling: novel insights from a colon organoid-based model to improve visceral pain therapy.

Francesco Margiotta, Elena Lucarini, Alessandra Toti, Lorenzo Curti, Alessio Masi, Tommaso Mello, Gwenaelle Le Gall, Gianluca Mattei, Alberto Magi, David Vauzour and 3 more

Abstract read
In one paragraph

Article in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. iScience · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesco MargiottaDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0002-4172-2478
Elena LucariniDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0002-3459-2660
Alessandra TotiDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0002-8435-6017
Lorenzo CurtiDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0001-9942-4193
Alessio MasiDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0002-0361-0950
Tommaso MelloDepartment of Clinical and Experimental Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.ORCID 0000-0002-6192-6902
Gwenaelle Le GallNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0002-1379-2196
Gianluca MatteiDepartment of Health Sciences, Clinical Pharmacology and Oncology Unit, University of Florence, Florence, Italy.ORCID 0000-0002-7421-0663
Alberto MagiDepartment of Information Engineering, University of Florence, Florence, Italy.ORCID 0000-0001-7393-4283
David VauzourNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0001-5952-8756
Guido MannaioniDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0002-8273-7377
Lorenzo Di Cesare MannelliDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0001-8374-4432
Carla GhelardiniDepartment of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0001-9856-8144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic gastrointestinal pain is a hallmark of most intestinal pathologies, yet effective treatments remain elusive given the complexity of the underlying mechanisms. Aiming to investigate the intestinal epithelium contribution to visceral pain modulation in dysbiosis context, we first demonstrated that intracolonic instillation of microbe-free fecal supernatants from mice with post-inflammatory dysbiosis induced by dextran sodium sulfate (FS

Indexed as

ColonDysbiosisGastrointestinal MicrobiomeIntestinal MucosaNeuronsOrganoidsVisceral PainAnimalsDextran SulfateDisease Models, AnimalFatty Acids, VolatileGanglia, SpinalMaleMiceMice, Inbred C57BLSignal TransductionDextran SulfateFatty Acids, VolatileDRG neuronsdysbiosisepithelial-neuronal signalingintestinal epitheliummicrobiotaorganoidsVisceral pain

Identifiers

PMID40903878
PMCPMC12413070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.